NDC 67457-951-00 - Heparin sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 67457-951
- Requested NDC
- 67457-951-00
- Package NDCs from labels
- 67457-951-00, 67457-951-01
- Manufacturer
- Mylan Institutional LLC
- Effective date
- 2019-09-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Heparin sodium - Mylan Institutional LLC | Mylan Institutional LLC | 2019-09-13 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 67457-951-00 | ML - Milliliter | 67457-951 | 46a3828c-63f1-4d9b-a6f8-2dba28eb8356 | 1 | 2019-07-02 |
| 67457-951-01 | ML - Milliliter | 67457-951 | 728b2849-a650-442f-b73b-5227824987f2 | 1 | 2019-07-02 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Heparin Sodium | HEPARIN SODIUM | Hospira, Inc. | c8c4edd2-ee9e-4558-6b8c-b83adc242a0a | 2026-08-25 | Warnings, Adverse reactions | ZZ45AB24CA |
| Heparin Sodium | HEPARIN SODIUM | Henry Schein, Inc. | 45dc6b8b-ed5d-40a2-8d9c-084c863ae93a | 2026-08-19 | Warnings, Adverse reactions | ZZ45AB24CA |
| Heparin Sodium | HEPARIN SODIUM | Cardinal Health 107, LLC | 239b4816-6a55-451b-bf40-e611be07d12f | 2026-08-10 | Warnings, Adverse reactions | ZZ45AB24CA |
| Heparin Sodium | HEPARIN SODIUM | Cardinal Health 107, LLC | 9ea0a519-dc7c-42e3-939e-2a7c80eedd25 | 2026-07-10 | Warnings, Adverse reactions | ZZ45AB24CA |
| Heparin Sodium | HEPARIN SODIUM | Cardinal Health 107, LLC | e0cc5f44-9a67-4274-a48a-d6118e96d391 | 2026-06-25 | Warnings, Adverse reactions | ZZ45AB24CA |
| BM BM182 DROPS | HEPAR SULF, GRAPHITES, MERC SOL, MURIATIC ACID | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5423bde6-3e31-38b0-e063-6294a90afb2d | 2026-06-13 | Warnings | QTT17582CB |
| BM BM182 DROPS | HEPAR SULF, GRAPHITES, MERC SOL, MURIATIC ACID | BM Private Limited | 540d11e3-e4a1-0ca2-e063-6394a90a3c26 | 2026-06-12 | Warnings | QTT17582CB |
| Heparin Sodium | HEPARIN SODIUM | Cardinal Health 107, LLC | 62cfd1bb-894f-4429-b362-1e40981dccc6 | 2026-06-11 | Warnings, Adverse reactions | ZZ45AB24CA |
| Heparin Sodium | HEPARIN SODIUM | Cardinal Health 107, LLC | 9cd7abe6-3923-4007-8491-273ef6e05ad7 | 2026-06-02 | Warnings, Adverse reactions | ZZ45AB24CA |
| Heparin Sodium and Dextrose | HEPARIN SODIUM | Hospira, Inc. | eede8a0c-5ae6-4166-84b3-12081405f08e | 2026-05-25 | Warnings, Adverse reactions | ZZ45AB24CA |
| Muriaticum acidum | HYDROCHLORIC ACID | Boiron | 8643bc58-bb0e-5c79-e053-2991aa0a02ae | 2026-05-19 | Warnings | QTT17582CB |
| Heparin Sodium | HEPARIN SODIUM | Cardinal Health 107, LLC | f67eea4e-80ff-48da-8b04-8addc5cd31d1 | 2026-05-12 | Warnings, Adverse reactions | ZZ45AB24CA |
| Heparin Sodium | HEPARIN SODIUM | Hospira, Inc. | 0413f511-6b34-4c15-e48b-3fad08baacbe | 2026-05-12 | Warnings, Adverse reactions | ZZ45AB24CA |
| Heparin Sodium | HEPARIN SODIUM | Hospira, Inc. | 32e34077-aff1-4ec7-f9b0-b8e240768fb8 | 2026-05-12 | Warnings, Adverse reactions | ZZ45AB24CA |
| HEPARIN SODIUM | HEPARIN SODIUM | HF Acquisition Co LLC, DBA HealthFirst | 51197aa6-de34-3a55-e063-6294a90a89c9 | 2026-05-05 | Warnings, Adverse reactions | ZZ45AB24CA |
| Heparin Sodium | HEPARIN SODIUM | Fresenius Kabi USA, LLC | 2a173253-dfdc-4d9d-8dee-b9c13e6fa9f5 | 2026-04-30 | Warnings, Adverse reactions | ZZ45AB24CA |
| Heparin Sodium | HEPARIN SODIUM | Plano Pharmaceuticals Inc. | 4deaa9ac-91aa-d96b-e063-6294a90a47bd | 2026-03-25 | Warnings, Adverse reactions | ZZ45AB24CA |
| Heparin Sodium | HEPARIN SODIUM | Hospira, Inc. | 6c181d7e-aed2-4975-30ac-d39a94cca7ec | 2026-03-24 | Warnings, Adverse reactions | ZZ45AB24CA |
| Skin Irritations and Itch Relief | AGARICUS MUSCARIUS, ALUMINA, ANAGALLIS ARVENSIS, ANTIMONIUM TARTARICUM, APIS MELLIFICA, ARSENICUM ALBUM, ARSENICUM IODATUM, BOVISTA, CAUSTICUM, DOLICHOS PRURIENS, FAGOPYRUM ESCULENTUM, GRAPHITES, KALI MURIATICUM, MURIATICUM ACIDUM, OLEANDER, PETROLEUM, PIX LIQUIDA, RADIUM BROMATUM (12X, 30X, 1LM), RHUS TOX, SELENIUM METALLICUM, SULPHUR AND URTICA URENS. | King Bio Inc. | d139d2f1-0369-4963-9f3d-c4cc0f1ea2dd | 2026-03-10 | Warnings | QTT17582CB |
| Heparin Sodium | HEPARIN SODIUM | Medical Purchasing Solutions, LLC | 4c118b39-cb4e-31a9-e063-6394a90a41b0 | 2026-03-02 | Warnings, Adverse reactions | ZZ45AB24CA |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.